These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Epstein-Barr virus: dermatologic associations and implications: part II. Associated lymphoproliferative disorders and solid tumors. Eminger LA; Hall LD; Hesterman KS; Heymann WR J Am Acad Dermatol; 2015 Jan; 72(1):21-34; quiz 35-6. PubMed ID: 25497918 [TBL] [Abstract][Full Text] [Related]
5. Immunotherapy for Epstein-Barr virus-associated cancers in children. Straathof KC; Bollard CM; Rooney CM; Heslop HE Oncologist; 2003; 8(1):83-98. PubMed ID: 12604735 [TBL] [Abstract][Full Text] [Related]
6. The contribution of the Epstein-Barr virus to the pathogenesis of childhood lymphomas. Cader FZ; Kearns P; Young L; Murray P; Vockerodt M Cancer Treat Rev; 2010 Jun; 36(4):348-53. PubMed ID: 20193983 [TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus and cancer. Thompson MP; Kurzrock R Clin Cancer Res; 2004 Feb; 10(3):803-21. PubMed ID: 14871955 [TBL] [Abstract][Full Text] [Related]
11. Molecular detection of Epstein-Barr virus in different types of lymphoma. Shaklawoon K; Altagazi N; Altorjman F; Alturki A; Eltaweel M; Alqawi O Mol Biol Rep; 2020 Mar; 47(3):1803-1807. PubMed ID: 31993862 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus in Hodgkin's disease. Chapman AL; Rickinson AB Ann Oncol; 1998; 9 Suppl 5():S5-16. PubMed ID: 9926231 [TBL] [Abstract][Full Text] [Related]
13. Assessment of Epstein-Barr virus association with pediatric non-hodgkin lymphoma in immunocompetent and in immunocompromised patients in Argentina. Chabay PA; De Matteo EN; Aversa L; Maglio S; Grinstein S; Preciado MV Arch Pathol Lab Med; 2002 Mar; 126(3):331-5. PubMed ID: 11860309 [TBL] [Abstract][Full Text] [Related]
14. Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease. Berger C; Day P; Meier G; Zingg W; Bossart W; Nadal D J Med Virol; 2001 Aug; 64(4):505-12. PubMed ID: 11468736 [TBL] [Abstract][Full Text] [Related]
15. Infection with Epstein-Barr virus and cancer: an epidemiological review. Serraino D; Piselli P; Angeletti Cl; Scuderi M; Ippolito G; Capobianchi MR J Biol Regul Homeost Agents; 2005; 19(1-2):63-70. PubMed ID: 16178276 [TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for Epstein-Barr virus-associated malignancies. Long HM; Parsonage G; Fox CP; Lee SP Drug News Perspect; 2010 May; 23(4):221-8. PubMed ID: 20520851 [TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus: the first human tumor virus and its role in cancer. Pagano JS Proc Assoc Am Physicians; 1999; 111(6):573-80. PubMed ID: 10591086 [TBL] [Abstract][Full Text] [Related]
19. Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus. Gutiérrez MI; Ibrahim MM; Dale JK; Greiner TC; Straus SE; Bhatia K J Natl Cancer Inst; 2002 Dec; 94(23):1757-63. PubMed ID: 12464647 [TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study. Leong IT; Fernandes BJ; Mock D Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]